biomarkers

You have access
Tissue Expression and Prognostic Role of CXCL12 and CXCR4 in High-grade Serous Ovarian Carcinoma
HYUNJI LIM, SE IK KIM, EUN NA KIM, MARIA LEE, CHEOL LEE, JAE-WEON KIM and HYUN HOON CHUNG

Anticancer Research July 2023, 43 (7) 3331-3340; DOI: https://doi.org/10.21873/anticanres.16509
Open Access
The Role of Genetic Polymorphisms in the Diagnosis and Management of Prostate Cancer: An Update
LUCIO DELL’ATTI and GIANLUCA AGUIARI

Anticancer Research January 2023, 43 (1) 317-322; DOI: https://doi.org/10.21873/anticanres.16166
Open Access
Integrin Expression in Localized Prostate Cancer: A TCGA and MSKCC Cohort-based Exploratory In Silico Analysis
MANUEL NEUBERGER, LISA FREY, KATJA NITSCHKE, FREDERIK WESSELS, NIKLAS WESTHOFF, FRANK WALDBILLIG, MALIN NIENTIEDT, FRIEDRICH HARTUNG, JOST VON HARDENBERG, MAURICE STEPHAN MICHEL, PHILIPP ERBEN, PHILIPP NUHN and THOMAS STEFAN WORST

Anticancer Research January 2023, 43 (1) 417-428; DOI: https://doi.org/10.21873/anticanres.16177
You have access
Baseline Modified Glasgow Prognostic Score (mGPS) Predicts Radiologic Response and Overall Survival in Metastatic Hormone-sensitive Prostate Cancer Treated With Docetaxel Chemotherapy
MANUEL NEUBERGER, JANINA SKLADNY, NORA GOLY, FREDERIK WESSELS, CHRISTEL WEIß, LUISA EGEN, PHILIPP ERBEN, MATTHIAS GROß-WEEGE, BRITTA GRÜNE, FRIEDRICH HARTUNG, JONAS HERRMANN, PATRICK HONECK, JONAS JARCZYK, KARL-FRIEDRICH KOWALEWSKI, JULIA MÜHLBAUER, KATJA NITSCHKE, MALIN NIENTIEDT, MARGARETE THERESA WALACH, FRANK WALDBILLIG, NIKLAS WESTHOFF, JOST VON HARDENBERG, MAXIMILIAN KRIEGMAIR, THOMAS S. WORST and PHILIPP NUHN

Anticancer Research April 2022, 42 (4) 1911-1918; DOI: https://doi.org/10.21873/anticanres.15668
You have access
Adjuvant Radiotherapy in Patients With Pancreatic Adenocarcinoma. Is It Still Appealing in Clinical Trials? A Meta-analysis and Review of the Literature
FRANCESCO PASQUALETTI, ALDO SAINATO, RICCARDO MORGANTI, CONCETTA LALISCIA, ENRICO VASILE, ALESSANDRA GONNELLI, SABRINA MONTRONE, GIOVANNI GADDUCCI, NOEMI GIANNINI, NATALINA COCCIA, TAIUSHA FUENTES, SOFIA ZANOTTI, MASSIMO FALCONI and FABIOLA PAIAR

Anticancer Research October 2021, 41 (10) 4697-4704; DOI: https://doi.org/10.21873/anticanres.15283
You have access
BAI1 as a Prognostic Marker of Clear Cell Renal Cell Carcinoma (ccRCC)
MARTIN PESTA, IVAN TRAVNICEK, VLASTIMIL KULDA, JINDRA WINDRICHOVA, HANA REZACKOVA, KATERINA HOUFKOVA, TEREZA MACANOVA, BARBORA BENDOVA, ANDREA NESTOROVA, ONDREJ HES, MILAN HORA, ONDREJ TOPOLCAN and JIRI POLIVKA

Anticancer Research September 2021, 41 (9) 4463-4470; DOI: https://doi.org/10.21873/anticanres.15255
You have access
Clinically Applicable Serum Biomarkers Among 14 Candidates Associated With Recurrence of Stage II and III Colorectal Cancer
CHAN WOOK KIM, YE JIN HA, KA HEE TAK, SEON AE ROH, SEON-KYU KIM, SEON-YOUNG KIM, YONG SUNG KIM, DONG-HYUNG CHO and JIN CHEON KIM

Anticancer Research September 2021, 41 (9) 4651-4658; DOI: https://doi.org/10.21873/anticanres.15279
You have access
Role of Ki-67, MRE11, and PD-L1 as Predictive Biomarkers for Recurrence Pattern in Muscle-invasive Bladder Cancer
CROIX C. FOSSUM, YIN XIONG, ANTHONY MAGLIOCCO, SIAMAK DANESHMAND, MANJU ARON, KENT W. MOUW, ZARKO MANOJLOVIC, SUSAN MCCARTHY, CHRISTINA PHUONG, TANYA DORFF, SUMEET K. BHANVADIA and LESLIE K. BALLAS

Anticancer Research August 2021, 41 (8) 3851-3857; DOI: https://doi.org/10.21873/anticanres.15178
You have access
Independent Validation of a Comprehensive Machine Learning Approach Predicting Survival After Radiotherapy for Bone Metastases
CARSTEN NIEDER, BÅRD MANNSÅKER and ROSALBA YOBUTA

Anticancer Research March 2021, 41 (3) 1471-1474; DOI: https://doi.org/10.21873/anticanres.14905
You have access
Neurological Death After Radiotherapy for Brain Metastases: Role of the LabBM Score
CARSTEN NIEDER, BÅRD MANNSÅKER and ROSALBA YOBUTA

Anticancer Research January 2021, 41 (1) 341-345; DOI: https://doi.org/10.21873/anticanres.14781

Main menu

User menu

Search

biomarkers

Pages